http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1765993

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 3874
issn 0950-9232
1476-5594
issueIdentifier 36
pageRange 3862-3874
publicationName Oncogene
startingPage 3862
bibliographicCitation Fournier G, Cabaud O, Josselin E, Chaix A, Adélaïde J, Isnardon D, Restouin A, Castellano R, Dubreuil P, Chaffanet M, Birnbaum D, Lopez M. Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth. Oncogene. 2011 Sep 08;30(36):3862–74. doi: 10.1038/onc.2011.106. PMID: 21478912.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be82553c6b946593b6b89f9a69b01862
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e754315260f7b544b3c83cd37b4a786
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0c79fecd45fcc3e149e355e1ee369b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8515377a25a8657f52b244f76d0848f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b81ae15c70cd2e0899efae209cd62edd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_927b00ec494d5ce685f358cb63ecae32
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab8b27bbb523083911a1718a00fd7edb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6f5b427b0ceea7ba7a70cf998bdb285
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfd8d479bdb8f6aa75f5a96cdf454dbc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2515b44a46f1765583d2bdb5d6b798c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b0aac27b41dc2f36eb1dfb19240ceb1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe946caff7519452a2ab6ba4a4a6fe5f
date 2011-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/21478912
https://doi.org/10.1038/onc.2011.106
isPartOf https://portal.issn.org/resource/ISSN/0950-9232
https://portal.issn.org/resource/ISSN/1476-5594
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6325
language English
source https://scigraph.springernature.com/
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth
discusses http://id.nlm.nih.gov/mesh/M0013781
http://id.nlm.nih.gov/mesh/M0251515
http://id.nlm.nih.gov/mesh/M0014361
http://id.nlm.nih.gov/mesh/M0025247
http://id.nlm.nih.gov/mesh/M0282640
http://id.nlm.nih.gov/mesh/M0471635
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_04c395ce1d98b55d50476409a26b1eee
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312137
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a1ea7596ec0db6cc9c3a3f852aef7546

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4301
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26955
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17356

Total number of triples: 49.